drugset / Trial / NCT03413358
Clinical Trial for Post-marketing Evaluation of Sheng Bai Oral Liquid
Unknown
240 enrolled
BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
Hubei Mon Yan Pharmaceutical Co., Ltd · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the efficacy and safety of Sheng Bai oral liquid in prevention and treatment of the decrease of neutrophilics after chemotherapy in patients with non-small-cell lung cancer.
Timeline
- Start
- 2018-01-15
- Primary completion
- 2019-10-31
- Completion
- 2019-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sheng Bai oral liquid | Unknown | 40 ml | Oral |
| Background | Carboplatin | Small molecule | — | — |
| Background | Cisplatin | Other / unclassified | — | — |